ReShape Lifesciences Inc

RSLS

$0.17

Closing

▼-0.24%

1D

▼-32.96%

YTD

RSLS

BBG0036S6JZ9

Market cap

$4.93M

52 week high

$0.78

52 week low

$0.14

Volume

38,190

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$4.93M

Analysts' Rating

HOLD

Price Target (Mean)

0.00

Total Analysts

0

P/E

Operating Margin

-82.70%

Beta

1.42

Revenue Growth

-12.82%

52 week high

$0.78

52 week low

$0.14

Div. Yield

%

EPS Growth

-29.73

Company Profile

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.